rxstat › Shortages › Metolazone
Metolazone (Zaroxolyn) shortage status
Partial shortage
A diuretic (water pill) used to treat fluid retention and high blood pressure.
Shortage history
Reports by product
What's happening
Metolazone is currently affected by an active shortage report filed with Health Canada by SANOFI-AVENTIS CANADA INC.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Metolazone is classified under “LOW-CEILING DIURETICS, EXCL THIAZIDES” (ATC C03BA).
Recent changes
- Oct 27, 2026 New report filed
- Aug 31, 2026 New report filed
Common questions
What is Metolazone used for?
A diuretic (water pill) used to treat fluid retention and high blood pressure.
When will Metolazone be back in stock in Canada?
The latest manufacturer estimate is Dec 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Metolazone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Possible alternatives in the same class (low-ceiling diuretics, excl thiazides)
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.